The effects of opioids on HIV reactivation in latently-infected T-lymphoblasts

被引:16
|
作者
Prottengeier, Johannes [1 ]
Koutsilieri, Eleni [2 ]
Scheller, Carsten [2 ]
机构
[1] Erlangen Univ Hosp, Dept Anesthesiol, D-91054 Erlangen, Germany
[2] Univ Wurzburg, Inst Immunol & Virol, D-97070 Wurzburg, Germany
来源
AIDS RESEARCH AND THERAPY | 2014年 / 11卷
关键词
HIV; Reactivation; Opioids; Heroine; Morphine; Naloxone; ACH-2; HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN PERIPHERAL-BLOOD; INJECTING DRUG-USERS; HOMOSEXUAL-MEN; DOCUMENTED DATES; CELL; EXPRESSION; MORPHINE; AIDS; PROGRESSION;
D O I
10.1186/1742-6405-11-17
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Opioids may have effects on susceptibility to HIV-infection, viral replication and disease progression. Injecting drug users (IDU), as well as anyone receiving opioids for anesthesia and analgesia may suffer the clinical consequences of such interactions. There is conflicting data between in vitro experiments showing an enhancing effect of opioids on HIV replication and clinical data, mostly showing no such effect. For clarification we studied the effects of the opioids heroin and morphine on HIV replication in cultured CD4-positive T cells at several concentrations and we related the observed effects with the relevant reached plasma concentrations found in IDUs. Methods: Latently-infected ACH-2 T lymphoblasts were incubated with different concentrations of morphine and heroine. Reactivation of HIV was assessed by intracellular staining of viral Gag p24 protein and subsequent flow cytometric quantification of p24-positive cells. The influence of the opioid antagonist naloxone and the antioxidants N-acetyl-cysteine (NAC) and glutathione (GSH) on HIV reactivation was determined. Cell viability was investigated by 7-AAD staining and flow cytometric quantification. Results: Morphine and heroine triggered reactivation of HIV replication in ACH-2 cells in a dose-dependent manner at concentrations above 1 mM (EC50 morphine 2.82 mM; EC50 morphine 1.96 mM). Naloxone did not interfere with heroine-mediated HIV reactivation, even at high concentrations (1 mM). Opioids also triggered necrotic cell death at similar concentrations at which HIV reactivation was observed. Both opioid-mediated reactivation of HIV and opioid-triggered cell death could be inhibited by the antioxidants GSH and NAC. Conclusions: Opioids reactivate HIV in vitro but at concentrations that are far above the plasma levels of analgesic regimes or drug concentrations found in IDUs. HIV reactivation was mediated by effects unrelated to opioid-receptor activation and was tightly linked to the cytotoxic activity of the substances at millimolar concentrations, suggesting that opioid-mediated reactivation of HIV was due to accompanying effects of cellular necrosis such as activation of reactive oxygen species and NF-kB.
引用
收藏
页数:6
相关论文
共 50 条
  • [11] Brain HIV-1 latently-infected reservoirs targeted by the suicide gene strategy
    Saeb, Sepideh
    Ravanshad, Mehrdad
    Pourkarim, Mahmoud Reza
    Daouad, Fadoua
    Baesi, Kazem
    Rohr, Olivier
    Wallet, Clementine
    Schwartz, Christian
    VIROLOGY JOURNAL, 2021, 18 (01)
  • [12] APOPTOSIS AS A MECHANISM OF CELL-DEATH IN CULTURED T-LYMPHOBLASTS ACUTELY INFECTED WITH HIV-1
    TERAI, C
    KORNBLUTH, RS
    PAUZA, CD
    RICHMAN, DD
    CARSON, DA
    JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (05): : 1710 - 1715
  • [13] Latently-infected CD4+T cells are enriched for HIV-1 Tat variants with impaired transactivation activity
    Yukl, Steven
    Pillai, Satish
    Li, Peilin
    Chang, Karen
    Pasutti, William
    Ahlgren, Chris
    Havlir, Diane
    Strain, Matthew
    Guenthard, Huldrych
    Richman, Douglas
    Rice, Andrew R.
    Daar, Eric
    Little, Susan
    Wong, Joseph K.
    VIROLOGY, 2009, 387 (01) : 98 - 108
  • [14] Elimination of latently HIV-1-infected cells by lymphoblasts armed with bifunctional antibody
    Yin, SP
    Okada, N
    Okada, H
    MICROBIOLOGY AND IMMUNOLOGY, 2001, 45 (01) : 101 - 108
  • [15] Polybacterial challenge enhances HIV reactivation in latently infected macrophages and dendritic cells
    Huang, Chifu B.
    Alimova, Yelena V.
    Strange, Samantha
    Ebersole, Jeffrey L.
    IMMUNOLOGY, 2011, 132 (03) : 401 - 409
  • [16] Dopamine activates HIV in chronically infected T lymphoblasts
    Scheller, C
    Sopper, S
    Jassoy, C
    ter Meulen, V
    Riederer, P
    Koutsilieri, E
    JOURNAL OF NEURAL TRANSMISSION, 2000, 107 (12) : 1483 - 1489
  • [17] Dopamine activates HIV in chronically infected T lymphoblasts
    C. Scheller
    S. Sopper
    C. Jassoy
    V. ter Meulen
    P. Riederer
    E. Koutsilieri
    Journal of Neural Transmission, 2000, 107 : 1483 - 1489
  • [18] HIV-1 reactivation in HIV-latently infected dendritic cells by oral microorganisms and LPS
    Huang, C. B.
    Alimova, Y. V.
    Ebersole, J. L.
    CELLULAR IMMUNOLOGY, 2011, 268 (02) : 105 - 111
  • [19] HIV Reactivation in Latently Infected Cells with Virological Synapse-Like Cell Contact
    Okutomi, Toshiki
    Minakawa, Satoko
    Hirota, Riku
    Katagiri, Koko
    Morikawa, Yuko
    VIRUSES-BASEL, 2020, 12 (04):
  • [20] Reactivation of Latent HIV-1 in Latently Infected Cells by Coumarin Compounds: Hymecromone and Scoparone
    Li, Xian
    Zeng, Hanxian
    Wang, Pengfei
    Lin, Lu
    Liu, Lin
    Zhen, Pinyi
    Fu, Yuanzhe
    Lu, Panpan
    Zhu, Huanzhang
    CURRENT HIV RESEARCH, 2016, 14 (06) : 484 - 490